| Busulfan studied in …STUDIED_INderived200 of 373show all (up to 200) |
|---|
| → studied in | NCT07524530Phase 2 · not yet recruiting Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775313Phase 1/Phase 2 · enrolling by invitation Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Burkitt Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · 373 trials list this drug (54 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327023Phase 1/Phase 2 · recruiting Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954987Phase 2 · not yet recruiting Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949129Phase 2/Phase 3 · recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183878NA · recruiting Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01961063Phase 1 · active not recruiting Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · 373 trials list this drug (54 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma,AIDS-Related Primary Effusion Lymphoma,AIDS-Related Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · 373 trials list this drug (54 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158828Phase 1/Phase 2 · recruiting Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228624Phase 2 · recruiting Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes · 373 trials list this drug (54 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762508NA · not yet recruiting A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565220Phase 1 · recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001385Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · 373 trials list this drug (54 active) | — | — | Lymphoma,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759102Phase 1 · not yet recruiting Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708054Phase 2/Phase 3 · recruiting Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207799Phase 2 · recruiting Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861417Phase 2 · active not recruiting Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259503Phase 1 · completed Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737769Phase 1 · not yet recruiting Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996119Phase 1 · recruiting Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04098393Phase 1 · active not recruiting Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02724163Phase 3 · active not recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802315Phase 2 · recruiting Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577094Phase 1/Phase 2 · withdrawn Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03247088Phase 1/Phase 2 · active not recruiting Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01702831Phase 2 · completed Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00534430Phase 2 · completed Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544115Phase 2 · active not recruiting Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01135329Phase 2 · terminated Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03613532Phase 1 · active not recruiting Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566377Phase 2 · recruiting Cord Blood Transplantation in Children and Young Adults With Blood Cancer · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01009840Phase 2 · completed IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872595Phase 2 · active not recruiting A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563920NA · not yet recruiting TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · 373 trials list this drug (54 active) | — | — | Hairy Cell Leukemia,Juvenile Myelomonocytic Leukemia,Mastocytosis+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02250937Phase 2 · active not recruiting Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04547049Phase 3 · active not recruiting A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735717Phase 2 · recruiting MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904588Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide · 373 trials list this drug (54 active) | — | — | Lymphoma,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644016Phase 2 · recruiting Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970096Phase 2 · recruiting Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565105Phase 2 · not yet recruiting CD34+ Transplants for Leukemia and Lymphoma · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441967Phase 2 · not yet recruiting The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170828Phase 1 · withdrawn Cryopreserved MMUD BM With PTCy for Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · 373 trials list this drug (54 active) | — | — | Digestive System Neoplasm,Germ Cell Tumor,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05917405Phase 2 · recruiting Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252870Phase 2 · recruiting Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175356Phase 1 · completed Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin · 373 trials list this drug (54 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121014Phase 2 · active not recruiting Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03674411Phase 2 · active not recruiting Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983850Phase 1/Phase 2 · active not recruiting Optimizing PTCy Dose and Timing · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349101Phase 2 · completed A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00534469Phase 2 · completed Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143830Phase 2 · recruiting HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016806recruiting Umbilical Cord Blood Transplantation From Unrelated Donors · 373 trials list this drug (54 active) | — | — | Solid Neoplasm,Lymphoma,Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579769Phase 2 · terminated Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · 373 trials list this drug (54 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,T-Cell Prolymphocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357565Phase 2 · completed Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia,Childhood Myelodysplastic Syndrome,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02793544Phase 2 · completed HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Lymphocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052422Phase 2/Phase 3 · not yet recruiting VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04690192Phase 1/Phase 2 · completed CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615105Phase 2 · terminated Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · 373 trials list this drug (54 active) | — | — | Solid Neoplasm,Adult Solid Neoplasm,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758328Phase 1 · completed Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506959Phase 2 · completed Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia,Plasmacytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701986Phase 1/Phase 2 · completed Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · 373 trials list this drug (54 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151706Phase 2 · completed CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04982354Phase 1/Phase 2 · withdrawn Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613035Phase 3 · not yet recruiting Twice-per-weekSelinexor, 2 Days Melphalan · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05569512Phase 1 · terminated Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML · 373 trials list this drug (54 active) | — | — | Childhood Malignant Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798004Phase 1 · completed Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 373 trials list this drug (54 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547196NA · completed AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337331Phase 2 · withdrawn Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02061800Phase 1/Phase 2 · unknown CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06297772Phase 3 · not yet recruiting Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR · 373 trials list this drug (54 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942730Phase 2 · completed Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · 373 trials list this drug (54 active) | — | — | Germ Cell Tumor,Central Nervous System Neoplasm,Hepatoblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441803Phase 2 · completed Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630565Phase 2/Phase 3 · terminated Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04220008Phase 2 · withdrawn Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma · 373 trials list this drug (54 active) | — | — | B-Cell Non-Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Transformed B-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128359Phase 2 · completed High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540995Phase 1/Phase 2 · terminated Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive,Myelodysplastic Syndrome with Excess Blasts+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823198Phase 1/Phase 2 · completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Erythroid Leukemia,Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240861Phase 1 · terminated Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer · 373 trials list this drug (54 active) | — | — | Malignant Neoplasm,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00611351Phase 2 · completed Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916979Phase 1 · completed Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG · 373 trials list this drug (54 active) | — | — | Lymphoma,Lymphoid Leukemia,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02248597Phase 2 · completed Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04002115Phase 2 · terminated Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044745Phase 2 · terminated Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Non-Hodgkin Lymphoma,Adult Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01203020Phase 2 · completed Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation · 373 trials list this drug (54 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01572662Phase 2 · completed Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning · 373 trials list this drug (54 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002868Phase 3 · completed Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049517Phase 3 · completed Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027000Phase 2 · completed Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688021Phase 2 · unknown A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02047578Phase 2 · unknown Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746173Phase 2 · terminated CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma · 373 trials list this drug (54 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282174Phase 2 · withdrawn CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02859402Phase 2 · recruiting Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas · 373 trials list this drug (54 active) | — | — | T-Cell Non-Hodgkin Lymphoma,Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119066Phase 2 · completed HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Secondary Myelodysplastic Syndrome,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05466318Phase 3 · unknown ChiCGB vs BEAM in High-risk or R/R Lymphomas · 373 trials list this drug (54 active) | — | — | Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01773395Phase 2 · terminated GVAX vs. Placebo for MDS/AML After Allo HSCT · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449899Phase 2/Phase 3 · unknown G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303727Phase 2 · not yet recruiting Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma · 373 trials list this drug (54 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247701NA · completed Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03303950Phase 2 · terminated Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis · 373 trials list this drug (54 active) | — | — | Multiple Myeloma,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600909Phase 2 · terminated A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02670252Phase 3 · completed BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02083250Phase 1 · completed Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471444Phase 3 · completed Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02120157Phase 2 · completed Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02660281Phase 1 · completed URMC Related Haplo-identical Donor BMT · 373 trials list this drug (54 active) | — | — | Solid Neoplasm,Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384212Phase 3 · unknown CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384225Phase 3 · unknown CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03018223Phase 1 · completed Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003816Phase 2/Phase 3 · completed Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01020539Phase 1 · completed Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia · 373 trials list this drug (54 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602898Phase 2 · withdrawn Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498016Phase 2 · unknown Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia · 373 trials list this drug (54 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129582Phase 1 · completed Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03795597Phase 1/Phase 2 · unknown Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · 373 trials list this drug (54 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01685411NA · terminated Busulfan and Cyclophosphamide Followed By ALLO BMT · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01338987Phase 2 · completed Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00813124Phase 2 · completed Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML) · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03515707Phase 2 · withdrawn Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469014Phase 2 · completed Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00176930NA · terminated Stem Cell Transplant for Hematological Malignancy · 373 trials list this drug (54 active) | — | — | Leukemia,Hodgkin Lymphoma,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469144Phase 3 · completed IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03530085Phase 2/Phase 3 · unknown Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005797Phase 2 · completed Bone Marrow Transplant in Treating Patients With Hematologic Cancers · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00612716Phase 2 · completed Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02799147Phase 1/Phase 2 · completed GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04451200Phase 2 · not yet recruiting Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning · 373 trials list this drug (54 active) | — | — | Acute Leukemia,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04127721Phase 2 · withdrawn Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01704716Phase 3 · recruiting High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) · 373 trials list this drug (54 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02544425Phase 2 · unknown VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) · 373 trials list this drug (54 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02750254Phase 1 · terminated Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822770Phase 1/Phase 2 · completed Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01605032Phase 2 · completed Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00836628Phase 1 · withdrawn Study of Busulfan for Refractory Central Nervous System (CNS) Tumors · 373 trials list this drug (54 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822393Phase 3 · completed Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC) · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00941720Phase 2 · completed Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003060Phase 1 · terminated Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma · 373 trials list this drug (54 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01237951Phase 2 · completed High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578292NA · terminated Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413178Phase 3 · completed A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553202Phase 2 · completed Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00857389Phase 2 · completed Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02671708Phase 2/Phase 3 · completed IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498316Phase 1 · completed Cord Blood Expansion on Mesenchymal Stem Cells · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01596699Phase 2 · terminated Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01749293Phase 2 · terminated Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation · 373 trials list this drug (54 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03385096Phase 2/Phase 3 · unknown Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT · 373 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01629511Phase 1/Phase 2 · terminated Allogeneic Stem Cell Transplant for CLL · 373 trials list this drug (54 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01983969Phase 1/Phase 2 · completed Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma · 373 trials list this drug (54 active) | — | — | Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605460Phase 2 · unknown Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission · 373 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02670109Phase 2 · unknown Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients · 373 trials list this drug (54 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03339700Phase 2 · unknown Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia · 373 trials list this drug (54 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01200329Phase 2 · completed High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease · 373 trials list this drug (54 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003270Phase 2 · completed Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02589145Phase 1/Phase 2 · terminated Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype · 373 trials list this drug (54 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707004Phase 2 · completed Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987636Phase 3 · completed Study in Localized and Disseminated Ewing Sarcoma · 373 trials list this drug (54 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123392Phase 2/Phase 3 · unknown Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04098653Phase 2/Phase 3 · unknown Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550992NA · unknown Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004088Phase 2 · completed Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475020Phase 2 · completed Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome · 373 trials list this drug (54 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627573Phase 2 · terminated Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT · 373 trials list this drug (54 active) | — | — | Leukemia,Myelodysplastic Syndrome,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801931Phase 1/Phase 2 · terminated Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00802113Phase 1/Phase 2 · completed Autologous and Allogeneic Transplant for Relapsed Lymphoma · 373 trials list this drug (54 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796562Phase 2 · completed Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416598Phase 2 · completed Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia, Myelodysplasia-Related,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943319Phase 1/Phase 2 · completed Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · 373 trials list this drug (54 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794167Phase 2 · completed BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma · 373 trials list this drug (54 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03792815Phase 2 · completed Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL) · 373 trials list this drug (54 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01824693Phase 2 · completed Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia · 373 trials list this drug (54 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03733327Phase 2/Phase 3 · unknown BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT · 373 trials list this drug (54 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043810Phase 1/Phase 2 · terminated Study of Gelonin Purging of Autologous Stem Cells for Transplantation · 373 trials list this drug (54 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02410551Phase 2 · terminated Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002831Phase 1/Phase 2 · completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057770Phase 1 · terminated Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134017Phase 2 · completed Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245115Phase 1 · terminated Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia · 373 trials list this drug (54 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333838Phase 2 · unknown Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies · 373 trials list this drug (54 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00990249Phase 2 · completed Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation · 373 trials list this drug (54 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602131Phase 2 · unknown Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma · 373 trials list this drug (54 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03596892Phase 2/Phase 3 · unknown Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT · 373 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03151876Phase 2 · unknown Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma · 373 trials list this drug (54 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070135Phase 2 · completed Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission · 373 trials list this drug (54 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |